ANPCF OTC
Cellbxhealth PLC
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +18.4%
1Y: -58.3%
3Y: -98.5%
5Y: -97.3%
$0.02
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$13M
+7.0% ▲
Capital Expenditures
$444K
+32.7% ▲
5Y CAGR: -5.7%
Free Cash Flow
-$14M
+8.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
+63.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$14M | -$17M | -$24M | -$22M | -$15M |
| Depreciation & Amort. | $1M | $1M | $3M | $2M | $2M |
| Stock-Based Comp. | $268K | $1M | $4M | $2M | $1M |
| Change in Working Capital | $228K | $606K | -$2M | -$1M | -$1M |
| Other Non-Cash Items | $14K | $128K | $232K | $4M | -$438K |
| Operating Cash Flow | -$8M | -$14M | -$16M | -$14M | -$13M |
| — Investing Activities — | |||||
| Capital Expenditures | -$506K | -$2M | -$2M | -$611K | -$411K |
| Acquisitions (Net) | $94K | $0 | $0 | $0 | $0 |
| Investment Purchases | -$2M | $0 | $0 | $0 | $0 |
| Investment Sales | -$2M | $17M | $0 | $0 | $0 |
| Other Investing | $2M | $24K | $136K | $408K | $363K |
| Investing Cash Flow | -$2M | $15M | -$2M | -$203K | -$48K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$463K | -$614K | -$814K | -$959K | -$805K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$44K | -$85K | -$135K | -$180K | -$158K |
| Financing Cash Flow | $18M | $19M | $18M | -$1M | $8M |
| Net Change in Cash | $8M | $20M | $57K | -$16M | -$6M |
| Cash End of Period | $12M | $32M | $32M | $16M | $10M |
| Free Cash Flow | -$8M | -$16M | -$18M | -$15M | -$14M |